A Russian venture capital fund has established an office in Boston, US, with plans to invest in the area’s biotech businesses, reports the Boston Herald.
The US$100 million Maxwell Biotech Venture Fund, which according to its website is the first Russian fund dedicated to life science investments, has set up an office in the Back Bay area of the city.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.